| Maryanne Schomig, OTR/L, CHT | |
|
2904 W Horizon Ridge Pkwy Ste 121, Henderson, NV 89052-5016 | |
| (702) 897-7331 | |
| (702) 897-6801 |
| Full Name | Maryanne Schomig |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 14 Years |
| Location | 2904 W Horizon Ridge Pkwy Ste 121, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053613869 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 10-0069 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dignity Select Nevada Llc | 0941541155 | 76 |
News Archive
The increasing prevalence of lifestyle-related health risks coupled with the lack of resources in preventative healthcare calls for novel and cost-efficient methods for supporting citizens in their independent health and well-being management. Behaviour modification is an efficient way of preventing chronic diseases and other lifestyle-related health problems, provided that the healthy behaviours are sustained over the long term.
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued non-final Actions Closing Prosecution in the reexamination proceedings for U.S. Pat. Nos. 6,833,252 ("the ‘252 patent") and 7,214,536 ("the ‘536 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Cure (UPMC), and licensed to Cellectis, SA (ALCLS). For the second time, the PTO has rejected all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that were not provided to the patent examiners during prosecution by the patent applicants.
The inventions of cell phones, personal computers, and the Internet ushered in the digital revolution and altered our existence in ways that were unimaginable just a few decades ago. But the most precious part of our existence-our health-has so far been largely unaffected and insulated from these innovations.
Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to 2 years. Sabril is the first drug in the United States approved to treat the disorder, characterized by a severe type of seizure that usually appears in the first year of life, typically between ages 4 months and 8 months.
› Verified 1 days ago
| Provider Name | Dignity Select Nevada Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1710446281 PECOS PAC ID: 0941541155 Enrollment ID: O20190610002405 |
News Archive
The increasing prevalence of lifestyle-related health risks coupled with the lack of resources in preventative healthcare calls for novel and cost-efficient methods for supporting citizens in their independent health and well-being management. Behaviour modification is an efficient way of preventing chronic diseases and other lifestyle-related health problems, provided that the healthy behaviours are sustained over the long term.
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued non-final Actions Closing Prosecution in the reexamination proceedings for U.S. Pat. Nos. 6,833,252 ("the ‘252 patent") and 7,214,536 ("the ‘536 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Cure (UPMC), and licensed to Cellectis, SA (ALCLS). For the second time, the PTO has rejected all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that were not provided to the patent examiners during prosecution by the patent applicants.
The inventions of cell phones, personal computers, and the Internet ushered in the digital revolution and altered our existence in ways that were unimaginable just a few decades ago. But the most precious part of our existence-our health-has so far been largely unaffected and insulated from these innovations.
Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to 2 years. Sabril is the first drug in the United States approved to treat the disorder, characterized by a severe type of seizure that usually appears in the first year of life, typically between ages 4 months and 8 months.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maryanne Schomig, OTR/L, CHT 2904 W Horizon Ridge Pkwy Ste 121, Henderson, NV 89052-5016 Ph: (702) 897-7331 | Maryanne Schomig, OTR/L, CHT 2904 W Horizon Ridge Pkwy Ste 121, Henderson, NV 89052-5016 Ph: (702) 897-7331 |
News Archive
The increasing prevalence of lifestyle-related health risks coupled with the lack of resources in preventative healthcare calls for novel and cost-efficient methods for supporting citizens in their independent health and well-being management. Behaviour modification is an efficient way of preventing chronic diseases and other lifestyle-related health problems, provided that the healthy behaviours are sustained over the long term.
Precision BioSciences, Inc., today announced that the United States Patent and Trademark Office (PTO) has issued non-final Actions Closing Prosecution in the reexamination proceedings for U.S. Pat. Nos. 6,833,252 ("the ‘252 patent") and 7,214,536 ("the ‘536 patent") that are owned by the Institut Pasteur and the Universite Pierre et Marie Cure (UPMC), and licensed to Cellectis, SA (ALCLS). For the second time, the PTO has rejected all claims under consideration as lacking novelty and/or as obvious in view of a variety of references, including many that were not provided to the patent examiners during prosecution by the patent applicants.
The inventions of cell phones, personal computers, and the Internet ushered in the digital revolution and altered our existence in ways that were unimaginable just a few decades ago. But the most precious part of our existence-our health-has so far been largely unaffected and insulated from these innovations.
Sabril (vigabatrin) Oral Solution has been approved by the U.S. Food and Drug Administration to treat infantile spasms in children ages 1 month to 2 years. Sabril is the first drug in the United States approved to treat the disorder, characterized by a severe type of seizure that usually appears in the first year of life, typically between ages 4 months and 8 months.
› Verified 1 days ago
Jahana Diiorio, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1176 Wigwam Pkwy, Henderson, NV 89074 Phone: 718-300-1331 | |
Kayla Cosgrove, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2850 W Horizon Ridge Pkwy Ste 320, Henderson, NV 89052 Phone: 702-564-4116 Fax: 702-932-2403 | |
Ms. June Marie Acompanado, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 969 Via Arenula St, Henderson, NV 89052 Phone: 702-883-6542 Fax: 702-837-4890 | |
Ren Montgomery Gilleo, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9011 Sierra Palms Way, Henderson, NV 89074 Phone: 702-227-4477 | |
Tyler Trees, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2401 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-458-1300 | |
Christen Leach, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2460 Kaymin Ridge Rd, Henderson, NV 89052 Phone: 702-371-3994 | |
Rebecca Hecht, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1781 Clear River Falls Ln, Henderson, NV 89012 Phone: 443-791-4739 |